Literature DB >> 9095173

Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice.

K A Klein1, R E Reiter, J Redula, H Moradi, X L Zhu, A R Brothman, D J Lamb, M Marcelli, A Belldegrun, O N Witte, C L Sawyers.   

Abstract

Prostate cancer mortality results from metastasis to bone and hormone-independent tumor growth. Models to study these progressive changes are lacking. Here we describe the propagation of advanced human prostate cancer by direct transfer of surgical samples from patients into immune-deficient male SCID mice. Explants from six of eight patients formed prostate tumors and two showed unique cytogenetic, biologic and molecular features that were retained through six or more passages. One grew in an androgen-independent fashion, whereas the second formed tumors that regressed following castration then regrew. Micrometastatic disease was detected in the hematopoietic tissues of half of the recipient mice. Thus selected specimens of advanced human prostate cancer can be propagated in SCID mice in a manner that recapitulates the clinical transition from androgen-sensitive to androgen-independent growth, accompanied by micrometastasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9095173     DOI: 10.1038/nm0497-402

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  143 in total

1.  Adrenal androgens rescue prostatic dihydrotestosterone production and growth of prostate cancer cells after castration.

Authors:  Yue Wu; Li Tang; Gissou Azabdaftari; Elena Pop; Gary J Smith
Journal:  Mol Cell Endocrinol       Date:  2019-02-23       Impact factor: 4.102

2.  Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancer.

Authors:  Ziyue Karen Jiang; Makoto Sato; Liu H Wei; Chinghai Kao; Lily Wu
Journal:  Cancer Res       Date:  2011-09-20       Impact factor: 12.701

3.  Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy.

Authors:  Makoto Sato; Mai Johnson; Liqun Zhang; Baohui Zhang; Kim Le; Sanjiv S Gambhir; Michael Carey; Lily Wu
Journal:  Mol Ther       Date:  2003-11       Impact factor: 11.454

4.  A novel association between the human heat shock transcription factor 1 (HSF1) and prostate adenocarcinoma.

Authors:  A T Hoang; J Huang; N Rudra-Ganguly; J Zheng; W C Powell; S K Rabindran; C Wu; P Roy-Burman
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

5.  A neuroendocrine/small cell prostate carcinoma xenograft-LuCaP 49.

Authors:  Lawrence D True; Kent Buhler; Janna Quinn; Emily Williams; Peter S Nelson; Nigel Clegg; Jill A Macoska; Thomas Norwood; Alvin Liu; William Ellis; Paul Lange; Robert Vessella
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Role of WNT7B-induced noncanonical pathway in advanced prostate cancer.

Authors:  Dali Zheng; Keith F Decker; Tianhua Zhou; Jianquan Chen; Zongtai Qi; Kathryn Jacobs; Katherine N Weilbaecher; Eva Corey; Fanxin Long; Li Jia
Journal:  Mol Cancer Res       Date:  2013-02-05       Impact factor: 5.852

7.  AR inhibitors identified by high-throughput microscopy detection of conformational change and subcellular localization.

Authors:  Jeremy O Jones; W Frank An; Marc I Diamond
Journal:  ACS Chem Biol       Date:  2009-03-20       Impact factor: 5.100

8.  A comparison of prostate cancer cell transcriptomes in 2D monoculture vs 3D xenografts identify consistent gene expression alterations associated with tumor microenvironments.

Authors:  Lauren Brady; Rui M Gil da Costa; Ilsa M Coleman; Clinton K Matson; Michael C Risk; Roger T Coleman; Peter S Nelson
Journal:  Prostate       Date:  2020-02-18       Impact factor: 4.104

9.  17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals.

Authors:  Yaming Qiao; Zhi-Kai Zhang; Li-Qun Cai; Chen Tan; Julianne L Imperato-McGinley; Yuan-Shan Zhu
Journal:  Prostate       Date:  2007-12-01       Impact factor: 4.104

Review 10.  Current mouse and cell models in prostate cancer research.

Authors:  Xinyu Wu; Shiaoching Gong; Pradip Roy-Burman; Peng Lee; Zoran Culig
Journal:  Endocr Relat Cancer       Date:  2013-06-24       Impact factor: 5.678

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.